Sunday, February 5, 2012
"The source for European pharmaceutical biotechnology news..."
How the minefield that is socia media could actually prove beneficial for the world of pharma.
1 of 11
Previous |
Next
Executive Interviews
The source is out
As outsourcing evolves once again to accommodate the shift in industry perspective, Dr. Reddys continues to place itself on its leading edge.
No Comments
Balancing act: aligning competing strategic objectives in turbulent times
IMS offers insight to new commercial model and launch excellence initiatives.
No Comments
REACH for the stars
Ali S. Faqi discusses the implications of the REACH initiative for manufacturers of chemical substances. Dr. Faqi, DVM, PhD, DABT is Director of the Developmental and Reproductive Toxicology (DART) team and Senior Principal Study Director at MPI Research.
No Comments
The helping hand
Mike Butler explains how Xceleron is helping its clients to answer critical clinical development questions.
No Comments
1 of 11
Previous |
Next
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.